Stephen J Thomas

Summary

Affiliation: Armed Forces Research Institute of Medical Sciences
Country: Thailand

Publications

  1. doi request reprint Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development
    Stephen J Thomas
    Department of Virology, Armed Forces Research Institute of Medical Sciences, 315 6 Rajvithi Road, Bangkok 10400, Thailand
    Vaccine 27:355-68. 2009
  2. pmc Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance
    Stephen J Thomas
    Department of Virology, United States Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Am J Trop Med Hyg 81:825-33. 2009
  3. ncbi request reprint Vaccines for the prevention of dengue: development update
    Stephen J Thomas
    Department of Virology, US Army Medical Component Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Hum Vaccin 7:674-84. 2011
  4. pmc Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants
    Veerachai Watanaveeradej
    Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand
    Am J Trop Med Hyg 85:341-51. 2011
  5. doi request reprint A model international partnership for community-based research on vaccine-preventable diseases: The Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU)
    Robert V Gibbons
    Armed Forces Research Institute of Medical Science, Department of Virology, Bangkok, Thailand Electronic address
    Vaccine 31:4487-500. 2013
  6. ncbi request reprint Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children
    Sriluck Simasathien
    Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand
    Am J Trop Med Hyg 78:426-33. 2008
  7. pmc Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006
    Jessica R Fried
    Mahidol Oxford Tropical Medicine Research Unit MORU, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    PLoS Negl Trop Dis 4:e617. 2010
  8. ncbi request reprint Dengue epidemiology: virus epidemiology, ecology, and emergence
    Stephen J Thomas
    Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Adv Virus Res 61:235-89. 2003

Detail Information

Publications8

  1. doi request reprint Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development
    Stephen J Thomas
    Department of Virology, Armed Forces Research Institute of Medical Sciences, 315 6 Rajvithi Road, Bangkok 10400, Thailand
    Vaccine 27:355-68. 2009
    ....
  2. pmc Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance
    Stephen J Thomas
    Department of Virology, United States Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Am J Trop Med Hyg 81:825-33. 2009
    ..Investigators varied cell type, control virus passage, and the use of complement across multiple assay runs of the same sample panel. Our findings indicate wide variation in PRNT titer results in response to varied testing conditions...
  3. ncbi request reprint Vaccines for the prevention of dengue: development update
    Stephen J Thomas
    Department of Virology, US Army Medical Component Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Hum Vaccin 7:674-84. 2011
    ..In this review the authors discuss dengue vaccines currently in the pre-clinical and clinical development pipeline...
  4. pmc Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants
    Veerachai Watanaveeradej
    Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand
    Am J Trop Med Hyg 85:341-51. 2011
    ..6% developed tetravalent neutralizing antibodies ≥ 1:10 to DENV (control group = 0%). This vaccine candidate, therefore, warrants continued development in this age group (NCT00322049; clinicaltrials.gov)...
  5. doi request reprint A model international partnership for community-based research on vaccine-preventable diseases: The Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU)
    Robert V Gibbons
    Armed Forces Research Institute of Medical Science, Department of Virology, Bangkok, Thailand Electronic address
    Vaccine 31:4487-500. 2013
    ..To provide a base for continuing studies, The Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU) was established. This paper reviews the origins of the collaboration and the scientific observations made between 1982 and 2012. ..
  6. ncbi request reprint Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children
    Sriluck Simasathien
    Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand
    Am J Trop Med Hyg 78:426-33. 2008
    ..gov NCT00384670)...
  7. pmc Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006
    Jessica R Fried
    Mahidol Oxford Tropical Medicine Research Unit MORU, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    PLoS Negl Trop Dis 4:e617. 2010
    ..It is unclear whether dengue serotypes differ in their propensity to cause severe disease. We analyzed differences in serotype-specific disease severity in children presenting for medical attention in Bangkok, Thailand...
  8. ncbi request reprint Dengue epidemiology: virus epidemiology, ecology, and emergence
    Stephen J Thomas
    Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Adv Virus Res 61:235-89. 2003